Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Subsequent events
Reply New Message
Prev Message Back To Forum Threaded View Next Message

8. Subsequent Events

During the period September 1, 2012 through October 10, 2012, we purchased 274,406 shares of our common stock at an aggregate cost of $28,780 pursuant to our stock buyback program

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply